H
HealthTell
The most accurate and affordable diagnostic platform for early detection and classification of complex diseases
About HealthTell
HealthTell, Inc. operated as a biotechnology firm focused on immune system profiling to facilitate early disease detection. Incorporated in 2012, the company was a spin-out from the Biodesign Institute at Arizona State University. The foundational technology, known as Immunosignature™, was developed by research scientists Stephen Albert Johnston and Neal Woodbury at ASU. Their work aimed to create a simple, inexpensive, and comprehensive method to assess health pre-symptomatically by analyzing the body's immune response.
The company's core offering was its proprietary Immunosignature™ technology, a platform designed to analyze the universe of antibodies in a single drop of blood. This was accomplished using high-density peptide arrays that act as a discovery platform, capturing patterns of antibody binding to create a unique "immunosignature" for an individual. This signature could reveal the presence of various diseases, including cancer, autoimmune disorders, and infectious diseases, with a high degree of accuracy. The technology required only a microliter of blood, which could be spotted on filter paper and mailed to their central laboratory in San Ramon, CA, for analysis.
HealthTell pursued a dual-track business model. A primary objective was the commercialization of diagnostic panels, with an initial focus on complex autoimmune diseases like lupus that are often difficult to diagnose. Simultaneously, the company established a pharmaceutical services division. This unit catered to biopharmaceutical clients, providing companion diagnostics to stratify patients for clinical trials and to identify individuals most likely to respond to specific therapies. Under the leadership of CEO Bill Colston, Ph.D., HealthTell secured significant funding, including a $14 million Series A round and a $26 million Series B round in March 2016, bringing its total raised capital to $40 million. In January 2017, HealthTell joined the Digital Life Alliance, an ecosystem of technology companies established by iCarbonX, which also became an investor. The company was ultimately acquired by iCarbonX in June 2018.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | Mar 2016 | $26M | $104M | Third Point Ventures | — |
| DEBT✓Debt | Sep 2015 | $5.2M | — | Undisclosed | — |
Growth signals
Latest recorded traffic for HealthTell is 1.7K monthly website visits, up 1207.7% over the last three months. HealthTell's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
HealthTell in the San Ramon ecosystem
The HealthTell office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Paladin Capital Group
Third Point Ventures
Other known investors3 additional known investors
Arizona State University
BlueTree Venture Fund
Small Business Innovation Research
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about HealthTell on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See HealthTell’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








